Results 191 to 200 of about 17,784 (227)

Chronic Refractory Cough

open access: yesChest, 2022
Chronic refractory cough (CRC) increasingly is recognised as a distinct clinical entity; cough that persists despite addressing potential aggravating factors (eg, asthma, acid reflux, angiotensin-converting enzyme medication).1 CRC is associated with ...
Peter S.P. Cho, Richard D. Turner
openaire   +2 more sources
Some of the next articles are maybe not open access.

Related searches:

Chronic Refractory Cough: Objective Improvement With Aerodynamic-Focused

Journal of Voice, 2021
Previous investigations have reported that a chronic cough that is refractory to medical therapies improves with behavioral therapies. However, the treatment parameters that may account for improvement in cough symptoms have not yet been objectively documented. The purpose of this study was to document changes in chronic refractory cough using a breath
Brianna K Crawley   +2 more
exaly   +3 more sources

Chronic Refractory Cough: A Case Study

open access: yesPerspectives of the ASHA Special Interest Groups, 2017
This paper presents a successful behavioral case study in treatment of chronic refractory cough in a 60-year-old adult female. The efficacy for speech-language pathology treating chronic cough is discussed along with description of treatment regime. Discussion focuses on therapy approaches used and the patient's report of changes in quality of life and
Anna Maria Siciliano
openaire   +2 more sources

Structural and Functional Correlates of Higher Cortical Brain Regions in Chronic Refractory Cough

open access: yesChest, 2022
Background: Chronic refractory cough significantly impairs the psychological and social aspects of quality of life. Loss of inhibitory control is suggested as a potential central neurobiological mechanism underlying chronic refractory cough.
Eun Namgung   +2 more
exaly   +2 more sources

Efficacy and safety of gefapixant, a P2X3 receptor antagonist, in refractory chronic cough and unexplained chronic cough (COUGH-1 and COUGH-2): results from two double-blind, randomised, parallel-group, placebo-controlled, phase 3 trials

open access: yesLancet, The, 2022
Background: Gefapixant is an oral P2X3 receptor antagonist that has previously shown efficacy and safety in refractory chronic cough and unexplained chronic cough.
Surinder S Birring   +2 more
exaly   +2 more sources

Management of chronic refractory cough

BMJ, 2015
Chronic refractory cough (CRC) is defined as a cough that persists despite guideline based treatment. It is seen in 20-46% of patients presenting to specialist cough clinics and it has a substantial impact on quality of life and healthcare utilization. Several terms have been used to describe this condition, including the recently introduced term cough
Gibson, Peter G., Vertigan, Anne E.
openaire   +2 more sources

Treatment of Chronic, Refractory Cough with Baclofen

Respiration, 1998
Chronic, nonproductive cough may result from enhanced sensitivity of the cough reflex. Often, this debilitating symptom is refractory to standard antitussive therapy. Baclofen, an agonist of γ-aminobutyric acid (GABA), has been shown, in animals, to have antitussive activity via a central mechanism.
P V, Dicpinigaitis, K, Rauf
openaire   +2 more sources

The Efficacy of Bradanicline in Refractory Chronic Cough

Airway pharmacology and treatment, 2020
Background: Several clinical studies have implicated nicotine in reducing cough reflex sensitivity in both healthy smoking and non-smoking subjects. Bradanicline, a highly selective α7 nicotinic acetylcholine receptor (nAChR) agonist, may therefore be effective for refractory chronic cough (RCC), possibly through sensory gating in the central nervous ...
Yoshihiro Kanemitsu   +6 more
openaire   +1 more source

Patient-Reported Qualitative Analysis of Chronic Refractory Cough

American Journal of Speech-Language Pathology, 2022
Purpose: Chronic cough has been shown to be associated with adverse effects on quality of life. There is a paucity of research characterizing quality-of-life factors associated with chronic refractory cough (CRC), a cough persisting > 8 weeks despite evaluation and treatment of possible etiologies.
Miranda L. Wright   +3 more
openaire   +2 more sources

The Healthcare Resource Utilization of Patients with Refractory Chronic Cough Compared to Those with Non-Refractory Chronic Cough

Lung
Refractory chronic cough (RCC) significantly impairs patient quality of life and poses a major challenge in clinical management. However, little is known about the healthcare resource utilization (HRU) of patients with RCC.The goal of our study is to describe the HRU and associated costs of RCC patients and those with non-refractory chronic cough (non ...
Guilleminault, Laurent   +7 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy